Genocea Biosciences Appoints Eric S. Hoffman As Chief Business Officer

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Eric S. Hoffman has joined the company as chief business officer.

“I am delighted to welcome Eric to Genocea at such an exciting time for the company as we progress our Phase 2 programs for the large genital herpes and pneumococcal markets,” said Chip Clark, president and chief executive officer of Genocea. “Eric brings proven business development credentials and deep industry and infectious disease experience to our team.”

Help employers find you! Check out all the jobs and post your resume.

Back to news